glp 1 and colon cancer GLP-1R Agonists Promote Normal Neoplastic Intestinal Growth through Mechanisms Requiring Fgf7: Cell Metabolism Does GLP-1 Cause Colon Cancer?

As stakeholders grapple with shortages and the emergence of compounded alternatives, its crucial to understand the current landscape and its implications for pharmacy benefits management

The healthcare provider conducts an extensive review of health history and current conditions before determining prescription suitability

These figures are from a published randomized controlled trial of the FDA-approved branded drug

News provided by NOVO NORDISK INC

Theres even the new Wegovy pill, approved in late 2025, to consider when thinking about pricing

In parallel, the landscape of pharmacological therapies for T2DM and (to a lesser extent) obesity has expanded in recent decades with new classes of molecules coming into the market